Published in AIDS Weekly, September 3rd, 2001
Andrea Antinori and colleagues at the National Institute for Infectious Diseases Lazzaro Spallanzani and Catholic University in Rome conducted a study to "evaluate the impact of response to highly active antiretroviral therapy (HAART) on the natural history of AIDS non-Hodgkin's lymphoma (NHL) and to analyse the feasibility, efficacy and toxicity of HAART in combination with chemotherapy." The results of their study were published in an August 2001 edition...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.